<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01176656</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-CUS-DUM-2010/1</org_study_id>
    <nct_id>NCT01176656</nct_id>
  </id_info>
  <brief_title>Hypoglycemia: Physician and Patient Perspectives</brief_title>
  <official_title>Hypoglycemia: Physician and Patient Perspectives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the burden of hypoglycemia and identify unmet need
      related to the management of hypoglycemia among Type 2Diabetes Mellitus (T2DM) patients on
      OADs and/or insulin. This is an observational study which will identify patients with T2DM in
      an administrative claims database and will link claims data with results of patient and
      physician surveys concerning hypoglycemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of hypoglycemia and impact of hypoglycemia</measure>
    <time_frame>October 2009-October 2010</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcomes of Hypoglycemia (including fear, awareness, behavioral modification and recovery from hypoglycemia)</measure>
    <time_frame>October 2009-October 2010</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment adherence and modification related to hypoglycemia, including health status, glycemic control and healthcare utilization</measure>
    <time_frame>October 2009-October 2010</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">800</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Hypoglycemia</condition>
  <arm_group>
    <arm_group_label>SU</arm_group_label>
    <description>T2DM patients with a prescription for a sulfonylurea but no insulin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antidiabetic without SU</arm_group_label>
    <description>T2DM patients with an oral antidiabetic drug other than an SU, and no insulin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Insulin</arm_group_label>
    <description>T2DM patients using insulin, with or without other oral antidiabetics</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with T2DM will be identified from a large U.S. administrative claims database
        using a claims-based algorithm for T2DM. Patients and their associated physicians will be
        recruited via mail into the survey portion of this study. Survey results will be linked to
        actual patient care using the claims records.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  T2DM claims diagnosis (algorithm-based) with at least 2 pharmacy claims for an
             antidiabetic drug

          -  at least 1 HbA1c test recorded during the identification period

          -  continuous enrollment in the health plan for at least 12 months prior to survey date

        Exclusion Criteria:

          -  Type 1 Diabetes Mellitus

          -  pregnancy or gestational diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Setareh Williams, PhD</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2010</study_first_submitted>
  <study_first_submitted_qc>August 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2010</study_first_posted>
  <last_update_submitted>September 12, 2011</last_update_submitted>
  <last_update_submitted_qc>September 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 Diabetes Mellitus</keyword>
  <keyword>Hypoglycemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Hypoglycemic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

